{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:03:53Z","timestamp":1784613833303,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"DOI":"10.1007\/s11655-026-4160-6","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:23:10Z","timestamp":1784611390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hyperoside Exerts Therapeutic Effects on Parkinson\u2019s Disease by Mitigating Oxidative Stress through Activation of Nrf2\/HO-1 Pathway"],"prefix":"10.1007","author":[{"given":"Si-xiang","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-shan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-yi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-xia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-nan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-rui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-chen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-guo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-jie","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"4160_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10571-019-00720-5","volume":"40","author":"OR Tamtaji","year":"2020","unstructured":"Tamtaji OR, Reiter RJ, Alipoor R, Dadgostar E, Kouchaki E, Asemi Z. Melatonin and Parkinson disease: current status and future perspectives for molecular mechanisms. Cell Molecul Neurobiol 2020;40:15\u201323.","journal-title":"Cell Molecul Neurobiol"},{"key":"4160_CR2","doi-asserted-by":"publisher","first-page":"1571074","DOI":"10.3389\/fimmu.2025.1571074","volume":"16","author":"AD Thome","year":"2025","unstructured":"Thome AD, Wang J, Atassi F, Thonhoff JR, Faridar A, Zhao W, et al. Peripheral monocyte transcriptional signatures of inflammation and oxidative stress in Parkinson\u2019s disease. Front Immunol 2025;16:1571074.","journal-title":"Front Immunol"},{"key":"4160_CR3","doi-asserted-by":"publisher","first-page":"102147","DOI":"10.1016\/j.arr.2023.102147","volume":"93","author":"J Burtscher","year":"2024","unstructured":"Burtscher J, Moraud EM, Malatesta D, Millet GP, Bally JF, Patoz A. Exercise and gait\/movement analyses in treatment and diagnosis of Parkinson\u2019s disease. Ageing Res Rev 2024;93:102147.","journal-title":"Ageing Res Rev"},{"key":"4160_CR4","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.2147\/DDDT.S189472","volume":"12","author":"N Chen","year":"2018","unstructured":"Chen N, Zhou Z, Li J, Li B, Feng J, He D, et al. 3-N-butylphthalide exerts neuroprotective effects by enhancing anti-oxidation and attenuating mitochondrial dysfunction in an in vitro model of ischemic stroke. Drug Design Develop Ther 2018;12:4261\u20134271.","journal-title":"Drug Design Develop Ther"},{"key":"4160_CR5","doi-asserted-by":"publisher","first-page":"eadu9555","DOI":"10.1126\/sciadv.adu9555","volume":"11","author":"XY Jiang","year":"2025","unstructured":"Jiang XY, Guo QQ, Wang SS, Guo R, Zou Y, Liu JW, et al. DNA damage response pathway regulates Nrf2 in response to oxidative stress. Sci Adv 2025;11:eadu9555.","journal-title":"Sci Adv"},{"key":"4160_CR6","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s11064-025-04557-x","volume":"50","author":"L Zhu","year":"2025","unstructured":"Zhu L, Lin L, Yang Z, Tang H, Wu J, Kang Z, et al. Sinomenine modifies Parkinson\u2019s disease through Nrf2 activation. Neurochem Res 2025;50:302.","journal-title":"Neurochem Res"},{"key":"4160_CR7","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.4103\/0028-3886.226451","volume":"66","author":"DM Radhakrishnan","year":"2018","unstructured":"Radhakrishnan DM, Goyal V. Parkinson\u2019s disease: a review. Neurol India 2018;66:S26\u2013S35.","journal-title":"Neurol India"},{"key":"4160_CR8","doi-asserted-by":"publisher","first-page":"154044","DOI":"10.1016\/j.phymed.2022.154044","volume":"100","author":"P Chen","year":"2022","unstructured":"Chen P, Zhang J, Wang C, Chai YH, Wu AG, Huang NY, et al. The pathogenesis and treatment mechanism of Parkinson\u2019s disease from the perspective of traditional Chinese medicine. Phytomedicine 2022;100:154044.","journal-title":"Phytomedicine"},{"key":"4160_CR9","doi-asserted-by":"publisher","first-page":"116540","DOI":"10.1016\/j.jep.2023.116540","volume":"313","author":"X Wang","year":"2023","unstructured":"Wang X, Yang C, Ru Y, Xie L, Xiao B, Jin X, et al. An optimal combination of five main monomer components in Wuzi Yanzong Pill that prevents neural tube defects and reduces apoptosis and oxidative stress. J Ethnopharm 2023;313:116540.","journal-title":"J Ethnopharm"},{"key":"4160_CR10","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1007\/s11011-023-01266-8","volume":"38","author":"T Pan","year":"2023","unstructured":"Pan T, Xiao Q, Fan HJ, Xu L, Qin SC, Yang LX, et al. Wuzi Yanzong Pill relieves MPTP-induced motor dysfunction and neuron loss by inhibiting NLRP3 inflammasome-mediated neuroinflammation. Metab Brain Dis 2023;38:2211\u20132222.","journal-title":"Metab Brain Dis"},{"key":"4160_CR11","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s11011-022-00993-8","volume":"37","author":"W Hang","year":"2022","unstructured":"Hang W, Fan HJ, Li YR, Xiao Q, Jia L, Song LJ, et al. Wuzi Yanzong Pill attenuates MPTP-induced Parkinson\u2019s disease via PI3K\/Akt signaling pathway. Metab Brain Dis 2022;37:1435\u20131450.","journal-title":"Metab Brain Dis"},{"key":"4160_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11655-022-3727-0","volume":"29","author":"YR Li","year":"2023","unstructured":"Li YR, Fan HJ, Sun RR, Jia L, Yang LY, Zhang HF, et al. Wuzi Yanzong Pill plays a neuroprotective role in Parkinson\u2019s disease mice via regulating unfolded protein response mediated by endoplasmic reticulum stress. Chin J Integr Med 2023;29:19\u201327.","journal-title":"Chin J Integr Med"},{"key":"4160_CR13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1186\/s12967-023-04459-y","volume":"21","author":"D Li","year":"2023","unstructured":"Li D, Xu J, Chang J, Wang Y, Du X, Wu H, et al. Hyperoside protects against oxidative stress-mediated photoreceptor degeneration: therapeutic potentials for photoreceptor degenerative diseases. J Transl Med 2023;21:569.","journal-title":"J Transl Med"},{"key":"4160_CR14","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s11011-022-01153-8","volume":"38","author":"XJ Xu","year":"2023","unstructured":"Xu XJ, Pan T, Fan HJ, Wang X, Yu JZ, Zhang HF, et al. Neuroprotective effect of hyperoside in MPP+\/MPTP-induced dopaminergic neurodegeneration. Metab Brain Dis 2023;38:1035\u20131050.","journal-title":"Metab Brain Dis"},{"key":"4160_CR15","doi-asserted-by":"publisher","first-page":"126920","DOI":"10.1016\/j.ijbiomac.2023.126920","volume":"253","author":"Y Shi","year":"2023","unstructured":"Shi Y, Zhou L, Zheng G, Jing Y, Zhang X, Yuan J, et al. Therapeutic mechanism exploration of polysaccharides from Dendrobium officinale on unilateral ureteral obstruction operation-induced renal fibrosis based on improving oxidative stress injury mediated by AhR\/NOX4 pathway. Int J Biol Macromol 2023;253:126920.","journal-title":"Int J Biol Macromol"},{"key":"4160_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.neuroscience.2024.10.048","volume":"563","author":"J Yuan","year":"2024","unstructured":"Yuan J, Dong X, Zhou S, Nao J. Pharmacological activities and therapeutic potential of hyperoside in the treatment of Alzheimer\u2019s and Parkinson\u2019s diseases: a systemic review. Neuroscience 2024;563:136\u2013147.","journal-title":"Neuroscience"},{"key":"4160_CR17","doi-asserted-by":"publisher","first-page":"105254","DOI":"10.1016\/j.neuint.2021.105254","volume":"152","author":"K Wang","year":"2022","unstructured":"Wang K, Lu C, Wang T, Qiao C, Lu L, Wu D, et al. Hyperoside suppresses NLRP3 inflammasome in Parkinson\u2019s disease via pituitary adenylate cyclase-activating polypeptide. Neurochem Int 2022;152:105254.","journal-title":"Neurochem Int"},{"key":"4160_CR18","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.12786\/bn.2022.15.e15","volume":"15","author":"SY Yoon","year":"2022","unstructured":"Yoon SY. Update on Parkinson\u2019s disease rehabilitation. Brain NeuroRehab 2022;15:e15.","journal-title":"Brain NeuroRehab"},{"key":"4160_CR19","doi-asserted-by":"publisher","first-page":"105686","DOI":"10.1016\/j.nbd.2022.105686","volume":"167","author":"W Shen","year":"2022","unstructured":"Shen W, Zhai S, Surmeier DJ. Striatal synaptic adaptations in Parkinson\u2019s disease. Neurobiol Dis 2022;167:105686.","journal-title":"Neurobiol Dis"},{"key":"4160_CR20","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.3390\/ijms23084176","volume":"23","author":"T Nagatsu","year":"2022","unstructured":"Nagatsu T, Nakashima A, Watanabe H, Ito S, Wakamatsu K. Neuromelanin in Parkinson\u2019s disease: tyrosine hydroxylase and tyrosinase. Int J Mol Sci 2022;23:4176.","journal-title":"Int J Mol Sci"},{"key":"4160_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13041-017-0340-9","volume":"10","author":"L Puspita","year":"2017","unstructured":"Puspita L, Chung SY, Shim JW. Oxidative stress and cellular pathologies in Parkinson\u2019s disease. Mol Brain 2017;10:53.","journal-title":"Mol Brain"},{"key":"4160_CR22","doi-asserted-by":"publisher","first-page":"9971885","DOI":"10.1155\/2021\/9971885","volume":"2021","author":"MA Akanji","year":"2021","unstructured":"Akanji MA, Rotimi DE, Elebiyo TC, Awakan OJ, Adeyemi OS. Redox homeostasis and prospects for therapeutic targeting in neurodegenerative disorders. Oxid Med Cell Longev 2021;2021:9971885.","journal-title":"Oxid Med Cell Longev"},{"key":"4160_CR23","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/hmg\/ddaa039","volume":"29","author":"RM Brazdis","year":"2020","unstructured":"Brazdis RM, Alecu JE, Marsch D, Dahms A, Simmnacher K, L\u00f6rentz S, et al. Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson\u2019s disease. Human Mol Genet 2020;29:1180\u20131191.","journal-title":"Human Mol Genet"},{"key":"4160_CR24","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3390\/antiox14060696","volume":"14","author":"ZZ Chong","year":"2025","unstructured":"Chong ZZ, Souayah N. Oxidative stress: pathological driver in chronic neurodegenerative diseases. Antioxidants (Basel) 2025;14:696.","journal-title":"Antioxidants (Basel)"},{"key":"4160_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bbrc.2017.06.190","volume":"500","author":"F Edlich","year":"2018","unstructured":"Edlich F. BCL-2 proteins and apoptosis: recent insights and unknowns. Biochem Biophys Res Commun 2018;500:26\u201334.","journal-title":"Biochem Biophys Res Commun"},{"key":"4160_CR26","doi-asserted-by":"publisher","first-page":"101890","DOI":"10.1016\/j.jchemneu.2020.101890","volume":"112","author":"R Balakrishnan","year":"2021","unstructured":"Balakrishnan R, Vijayraja D, Mohankumar T, Manimaran D, Ganesan P, Choi DK, et al. Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson\u2019s disease. J Chem Neuroanat 2021;112:101890.","journal-title":"J Chem Neuroanat"},{"key":"4160_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrd.2016.253","volume":"16","author":"A Ashkenazi","year":"2017","unstructured":"Ashkenazi A, Fairbrother WJ, Leverson JD, Souers AJ. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors. Nature Rev Drug Discov 2017;16:273\u2013284.","journal-title":"Nature Rev Drug Discov"},{"key":"4160_CR28","doi-asserted-by":"publisher","first-page":"6006","DOI":"10.1007\/s12035-016-0111-0","volume":"54","author":"R Zhang","year":"2017","unstructured":"Zhang R, Xu M, Wang Y, Xie F, Zhang G, Qin X. Nrf2-a promising therapeutic target for defensing against oxidative stress in stroke. Mol eurobiol 2017;54:6006\u20136017.","journal-title":"Mol eurobiol"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-4160-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-026-4160-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-4160-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:23:11Z","timestamp":1784611391000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-026-4160-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":28,"alternative-id":["4160"],"URL":"https:\/\/doi.org\/10.1007\/s11655-026-4160-6","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"9 February 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}